• Investigadors principals: Diana Puente Baliarda
• Còdi: 9F-0-00019-25
• Any d’inici: 2025

Post-authorisation safety study to evaluate the utilisation and safety of atogepant in patients with migraine and significant cardiovascular and/or cerebrovascular disease in European countries

• Investigadors principals: Talita Duarte Salles
• Còdi: 4RNC-0-00113-24
• Any d’inici: 2025
• Finançadors: Pharmo Institute N.V.

Atlas de prescripción farmacéutica en Diabetes

• Investigadors principals: Anna Moleras Serra, Anna Berenguera Ossó
• Còdi: 4RNC-0-00238-24
• Any d’inici: 2025

Atlas para la monitorización de los cuidados en Diabetes

• Investigadors principals: Anna Moleras Serra, Anna Berenguera Ossó
• Còdi: 4RNC-0-00270-24
• Any d’inici: 2025

A Non-Interventional Multi-Country Post-Authorisation Safety Study (PASS) to Assess the Incidence of Serious Infections & Malignancies in Systemic Lupus Erythematosus (SLE) Patients Exposed to Anifrolumab

• Investigadors principals: Rosa Morros Pedrós, Maria Giner Soriano
• Còdi: 4RNC-0-00379-25
• Any d’inici: 2026
• Finançadors: AstraZeneca Farmacéutica Spain, S.A.